Literature DB >> 19460295

PET imaging of redox and energy states in stroke-like episodes of MELAS.

Masamichi Ikawa1, Hidehiko Okazawa, Kenichiro Arakawa, Takashi Kudo, Hirohiko Kimura, Yasuhisa Fujibayashi, Masaru Kuriyama, Makoto Yoneda.   

Abstract

In stroke-like episodes of patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), changes in oxidative stress and glucose metabolism and their sequence remain obscure. We developed a novel double imaging method using positron emission tomography (PET) with [(62)Cu]-diacetyl-bis(N4-methylthiosemicarbazone) ((62)Cu-ATSM) and [(18)F]-fluorodeoxyglucose ((18)FDG) to visualize the regional oxidative stress, glucose metabolism and blood flow in brain lesions of stroke-like episodes non-invasively and rapidly. These PET imagings were performed on a MELAS patient with stroke-like lesions, and clearly demonstrated that oxidative stress following hyperemia along with increased glucose metabolism plays crucial roles in the pathogenesis of MELAS stroke-like episodes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460295     DOI: 10.1016/j.mito.2009.01.011

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  18 in total

1.  Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease.

Authors:  Makoto Isozaki; Yasushi Kiyono; Yoshikazu Arai; Takashi Kudo; Tetsuya Mori; Rikiya Maruyama; Ken-ichiro Kikuta; Hidehiko Okazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-02       Impact factor: 9.236

2.  Towards new horizons in brain PET.

Authors:  Marco Pagani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06       Impact factor: 9.236

Review 3.  Imaging of MELAS.

Authors:  Konark Malhotra; David S Liebeskind
Journal:  Curr Pain Headache Rep       Date:  2016-09

4.  The cellular basis of increased PET hypoxia tracer uptake in focal cerebral ischemia with comparison between [18F]FMISO and [64Cu]CuATSM.

Authors:  Philip V Little; Fabian Arnberg; Emma Jussing; Li Lu; Andreas Ingemann Jensen; Nicholas Mitsios; Jan Mulder; Thuy A Tran; Staffan Holmin
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-19       Impact factor: 6.200

Review 5.  Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.

Authors:  Stefanie M A Willekens; Donatienne Van Weehaeghe; Philip Van Damme; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-08       Impact factor: 9.236

Review 6.  Imaging Inflammation in Cerebrovascular Disease.

Authors:  Matthew J Gounis; Kajo van der Marel; Miklos Marosfoi; Mary L Mazzanti; Frédéric Clarençon; Ju-Yu Chueh; Ajit S Puri; Alexei A Bogdanov
Journal:  Stroke       Date:  2015-09-08       Impact factor: 7.914

Review 7.  Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).

Authors:  Suzanne E Lapi; Jason S Lewis; Farrokh Dehdashti
Journal:  Semin Nucl Med       Date:  2015-03       Impact factor: 4.446

8.  Pharmacological activity of metal binding agents that alter copper bioavailability.

Authors:  Marian E Helsel; Katherine J Franz
Journal:  Dalton Trans       Date:  2015-05-21       Impact factor: 4.390

9.  An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperII.

Authors:  Paul S Donnelly; Jeffrey R Liddell; SinChun Lim; Brett M Paterson; Michael A Cater; Maria S Savva; Alexandra I Mot; Janine L James; Ian A Trounce; Anthony R White; Peter J Crouch
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

10.  [64Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation.

Authors:  Fang Xie; Weijun Wei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-10       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.